We are FMOC-S-trityl-L-cysteine CAS:103213-32-7 manufacturer and supplier in China, Pls send inquiry of to email@example.com of visit www.nbinno.com our official website should you have any interests
Chemical Name: FMOC-S-trityl-L-cysteine
Molecular Weight: 585.71100
N-(9-Fluorenyl methoxy carbonyl)-S-trityl-L-cysteine
Physical and Chemical Properties:
Density: 1.27 g / cm3
Boiling point: 763.4ºC at 760 mmHg
Melting point: 170-173 ° C (lit.)
Flash point: 415.5ºC
Refractive index: 1.656
Appearance: White Crystalline Powder
Loss On Drying: ≤0.5%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at 2-8ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.Common inert gas protection.
Related News: Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs.2-bromo-9,9-dimethyl-10-phenyl-9,10-dihydroacridine “We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,” said Ed Damiano, President and CEO of Beta Bionics. “We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.”4-(Phthalimido)-Cyclohexanone The US National Institutes of Health is working on a preventative vaccine, but it will likely take a few months until the first phase of clinical trials get underway, and more than a year until a vaccine might be available, according to experts.1-fluoro-4-bromobutano CAS:462-72-6 The monthly injection to suppress the virus that causes AIDS was aimed as an alternative to daily pills.Analogous to master cell lines used to manufacture biopharmaceutical drug products such as monoclonal antibodies, clonal master iPSC lines are a renewable source for manufacturing cell therapy products which are well-defined and uniform in composition, can be mass produced at significant scale in a cost-effective manner, and can be delivered off-the-shelf for patient treatment.